Description. Our name, Xentria, is inspired by “centrality.” It describes our dedication to delivering adaptive approaches to ambitious drug innovation through authentic life-sciences partnerships. Established in 2020, we are a patient-centric biotech company focused on development of novel biologics and biosimilars. We collaborate with biopharmaceutic communities to create innovative solutions to challenging drug development. Our first program, ...